Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashi-ku, Hamamatsu, 431-3192, Japan.
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashi-ku, Hamamatsu, 431-3192, Japan.
Respir Med. 2019 Nov;159:105811. doi: 10.1016/j.rmed.2019.105811. Epub 2019 Nov 5.
Interstitial lung disease (ILD) is a condition characterized by a higher mortality rate in primary Sjögren's syndrome (pSS). However, factors influencing the outcome of patients with pSS-associated ILD remain unclear. The aim of the present study was to evaluate predictive factors associated with a worse prognosis in pSS-ILD.
This retrospective study included 99 consecutive patients with pSS-ILD. Clinical characteristics, laboratory findings, and pulmonary function tests at the time of diagnosis were analyzed. Chest HRCT images were reviewed by two experienced chest radiologists. Prognostic factors were assessed by univariate and multivariate analyses, using Cox proportional hazards regression model.
Median age was 68 years (73% women). In the total patient population, the 5- and 10-year survival rates were 89.8% and 79.0%, respectively. Univariate analysis revealed a significant association between prognosis and age, serum Krebs von den Lungen-6 (KL-6) levels, and %FVC. None of the chest HRCT findings were related to patient outcomes. Based on multivariate analyses adjusted by age and gender, lower levels of %FVC and higher levels of KL-6 were significantly associated with poor outcomes. Using optimal cutoff levels, according to receiver operating characteristic curve analyses, KL-6 > 800 U/mL were significantly associated with worse prognosis (HR: 2.91, 95% CI: 1.04-8.10). Patients with elevated serum KL-6 levels (>800 U/mL) showed a higher mortality rate than those without elevated serum KL-6 levels (p = 0.02).
Lower %FVC and higher serum KL-6 levels are predictive factors for poor outcome in patients with pSS-ILD.
间质性肺病(ILD)是原发性干燥综合征(pSS)的一种高死亡率特征。然而,影响 pSS 相关 ILD 患者预后的因素仍不清楚。本研究旨在评估与 pSS-ILD 预后较差相关的预测因素。
本回顾性研究纳入了 99 例连续的 pSS-ILD 患者。分析了诊断时的临床特征、实验室检查和肺功能检查。由两名有经验的胸部放射科医生对胸部 HRCT 图像进行了审查。使用 Cox 比例风险回归模型对预后因素进行了单因素和多因素分析。
中位年龄为 68 岁(73%为女性)。在总患者人群中,5 年和 10 年的生存率分别为 89.8%和 79.0%。单因素分析显示,预后与年龄、血清 Krebs von den Lungen-6(KL-6)水平和%FVC 显著相关。胸部 HRCT 检查结果与患者结局均无相关性。根据年龄和性别进行多因素调整分析,较低的%FVC 和较高的 KL-6 水平与不良预后显著相关。根据受试者工作特征曲线分析,最佳截断值时,KL-6>800 U/mL 与预后较差显著相关(HR:2.91,95%CI:1.04-8.10)。血清 KL-6 水平升高(>800 U/mL)的患者死亡率高于血清 KL-6 水平正常的患者(p=0.02)。
较低的%FVC 和较高的血清 KL-6 水平是 pSS-ILD 患者预后不良的预测因素。